Like Dexcom's, each system has smartphone capabilities and data monitoring and sharing applications. Available FreeStyle ...

"Abbott and Medtronic partner to integrate CGM system with insulin devices" was ... focusing on the integration of its ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

An AID system can drive much of your diabetes management once ... The company recently announced new CGM options for the future – including a Medtronic CGM that uses Freestyle Libre technology and a ...

For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve ...

Investors feel optimistic about Abbott's robust strength in the Core Diagnostics business. Yet, unfavorable forex impacts are concerning.

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

In November 2024, Insulet made its Omnipod 5 AID system compatible with Abbott’s FreeStyle Libre 2 Plus CGM sensor in the United States. In October 2024, the company made the full market release ...